We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PETDAG:MYXPetronas Dagangan Bhd. Analysis

Data as of 2026-05-22 - not real-time

MYR 18.02

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical indicators point to a bearish short‑term outlook – the price is trading below all major moving averages, the RSI sits in oversold territory and the MACD histogram is negative, suggesting continued downward pressure. Volume is rising, which could fuel further moves, and the current price is near a pivotal support level, making the near‑term risk of a breakdown tangible. Fundamentally, the company appears solid: revenue is growing at a healthy pace, cash balances vastly exceed debt, and profitability metrics, while modest, are supported by a strong return on equity. The valuation is attractive, with a price‑to‑earnings multiple well under the industry average and a dividend yield that ranks among the higher in the market, indicating potential upside for patient investors.
Given the high 30‑day volatility and a negative beta, price swings are likely to be pronounced but largely independent of broader market moves. The dividend payout is generous yet backed by robust operating cash flow, suggesting sustainability. While the sector faces commodity price and regulatory headwinds, the company’s diversified downstream operations and strong brand mitigate some of that exposure. Overall, the stock is positioned as undervalued with a compelling income component, but short‑term price action remains risky.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below key moving averages
  • oversold RSI and bearish MACD
  • proximity to technical support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation discount to industry peers
  • strong cash generation and low leverage
  • attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • sustainable dividend policy
  • stable earnings growth from downstream operations
  • low correlation with broader market movements

Key Metrics & Analysis

Financial Health

Revenue Growth17.60%
Profit Margin2.87%
P/E Ratio16.2
ROE18.75%
ROA8.64%
Debt/Equity2.69
P/B Ratio3.0
Op. Cash FlowMYR4.2B
Free Cash FlowMYR3.7B
Industry P/E21.5

Technical Analysis

TrendBearish
RSI29.8
SupportMYR 18.00
ResistanceMYR 21.38
MA 20MYR 20.11
MA 50MYR 20.83
MA 200MYR 21.34
MACDBearish
VolumeIncreasing
Fear & Greed Index91.48

Valuation

Fair ValueMYR 104.76
Target PriceMYR 21.88
Upside/Downside21.44%
GradeUndervalued
TypeBlend
Dividend Yield5.53%

Risk Assessment

Beta-0.11
Volatility34.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.